Responses to LPS boost effector CD8 T-cell accumulation outside of signals 1 and 2 | Cellular & Molecular Immunology
Vaccine Adjuvants Review | InvivoGen
Scientists Reveal Mechanisms for Superiority of PTX to LPS as Adjuvant for EAE Induction---Chinese Academy of Sciences
Aluminum Hydroxide Adjuvants Activate Caspase-1 and Induce IL-1β and IL-18 Release | The Journal of Immunology
The low‐toxicity versions of LPS, MPL® adjuvant and RC529, are efficient adjuvants for CD4+ T cells - Thompson - 2005 - Journal of Leukocyte Biology - Wiley Online Library
Lipopolysaccharide-enhanced, Toll-like Receptor 4–dependent T Helper Cell Type 2 Responses to Inhaled Antigen | Journal of Experimental Medicine | Rockefeller University Press
Improved immunogenicity of tetanus toxoid by Brucella abortus S19 LPS adjuvant. | Semantic Scholar
Lipopolysaccharide augments IgG and IgE responses of mice to the latex allergen Hev b 5 - Journal of Allergy and Clinical Immunology
Lipid A adjuvanted T cells in TRIF lps/lps recipients have impaired T... | Download Scientific Diagram
Frontiers | Mechanisms of Action of Adjuvants | Immunology
Vaccine adjuvant activity of a TLR4-activating synthetic glycolipid by promoting autophagy | Scientific Reports
The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4
Lipopolysaccharide - Creative Biolabs
TLR4 Agonists | LPS and Lipid A | InvivoGen
The Lipopolysaccharide Adjuvant Effect on T Cells Relies on Nonoverlapping Contributions from the MyD88 Pathway and CD11c+ Cells | The Journal of Immunology
Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases | Journal of The Royal Society Interface
Synthetic glycan-based TLR4 agonists targeting caspase-4/11 for the development of adjuvants and immunotherapeutics - Chemical Science (RSC Publishing) DOI:10.1039/C7SC05323A
Yuwen02f1 suppresses LPS-induced endotoxemia and adjuvant-induced arthritis primarily through blockade of ROS formation, NFkB and MAPK activation - ScienceDirect
Correlates of GLA family adjuvants' activities - ScienceDirect
A TLR4-derived non-cytotoxic, self-assembling peptide functions as a vaccine adjuvant in mice - Journal of Biological Chemistry
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients | Journal for ImmunoTherapy of Cancer | Full Text
Lipopolysaccharide-enhanced, Toll-like Receptor 4–dependent T Helper Cell Type 2 Responses to Inhaled Antigen | Journal of Experimental Medicine | Rockefeller University Press
Modulating the innate immune response by combinatorial engineering of endotoxin | PNAS
Synthetic glycan-based TLR4 agonists targeting caspase-4/11 for the development of adjuvants and immunotherapeutics - Chemical Science (RSC Publishing)
Carbomer-based adjuvant elicits CD8 T-cell immunity by inducing a distinct metabolic state in cross-presenting dendritic cells | PLOS Pathogens
Figure 7. Comparison of mono-phosphoryl lipid A and LPS structures. - Harnessing the Power of Microbes as Therapeutics: Bugs as Drugs - NCBI Bookshelf
TLR4 Agonists | LPS and Lipid A | InvivoGen
